Latest Filings

Issuer Activity

Insider Overview :: Microbix Biosystems Inc. (T:MBX) [?]
Business Focus: Biotechnology & Medical Research Share on StockTwits
Log in or sign up for a free account to add this stock to your watch list.

Holdings trends & enhanced charts available in PDF report. Click here for details »
Latest 10 SEDI filings (by transaction date) for MBX within the last 6 months [?]
Amended Filing
As of 11:59pm ET March 5th, 2015
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Jan 23/15 Jan 23/15 Marino, Martin Direct Ownership Common Shares 10 - Disposition in the public market -25,000 $0.720
Jan 23/15 Jan 22/15 Luscher, Mark Adrian Direct Ownership Common Shares 10 - Disposition in the public market -30,000 $0.711
Jan 13/15 Jan 13/15 Renner, Joseph David Direct Ownership Common Shares 51 - Exercise of options 50,000 $0.390
Jan 13/15 Jan 13/15 Renner, Joseph David Direct Ownership Options 51 - Exercise of options -50,000  
Jan 13/15 Jan 13/15 Cochran, Mark Direct Ownership Common Shares 11 - Disposition carried out privately -60,000  
Jan 13/15 Jan 13/15 Cochran, Mark Direct Ownership Common Shares 11 - Disposition carried out privately -140,000  
Jan 13/15 Jan 13/15 Cochran, Mark Direct Ownership Common Shares 51 - Exercise of options 200,000 $0.390
Jan 13/15 Jan 13/15 Cochran, Mark Direct Ownership Options 51 - Exercise of options -200,000  
Jan 12/15 Jan 12/15 Pollock, Andrew Christopher Direct Ownership Common Shares 51 - Exercise of options 50,000 $0.390
Jan 12/15 Jan 12/15 Pollock, Andrew Christopher Direct Ownership Options 51 - Exercise of options -50,000  
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by filing date) for MBX within the last 6 months [?]
Amended Filing
As of 11:59pm ET March 5th, 2015
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Jan 23/15 Jan 22/15 Luscher, Mark Adrian Direct Ownership Common Shares 10 - Disposition in the public market -30,000 $0.711
Jan 23/15 Jan 23/15 Marino, Martin Direct Ownership Common Shares 10 - Disposition in the public market -25,000 $0.720
Jan 13/15 Jan 9/15 Pollock, Andrew Christopher Direct Ownership Common Shares 10 - Disposition in the public market -3,000 $0.810
Jan 13/15 Jan 9/15 Pollock, Andrew Christopher Direct Ownership Common Shares 10 - Disposition in the public market -22,500 $0.800
Jan 13/15 Jan 9/15 Pollock, Andrew Christopher Direct Ownership Common Shares 10 - Disposition in the public market -3,000 $0.780
Jan 13/15 Jan 9/15 Pollock, Andrew Christopher Direct Ownership Common Shares 10 - Disposition in the public market -15,500 $0.770
Jan 13/15 Jan 9/15 Pollock, Andrew Christopher Direct Ownership Common Shares 10 - Disposition in the public market -6,000 $0.800
Jan 13/15 Jan 13/15 Renner, Joseph David Direct Ownership Common Shares 51 - Exercise of options 50,000 $0.390
Jan 13/15 Jan 13/15 Renner, Joseph David Direct Ownership Options 51 - Exercise of options -50,000  
Jan 13/15 Jan 13/15 Cochran, Mark Direct Ownership Common Shares 11 - Disposition carried out privately -60,000  
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Sign up for an account or login above to see the past 6 months of SEDI filings sorted by insider.
Markers (TSX Insider Summaries) for MBX on March 5, 2015 [?]
Marker Correction
Trading Date Ticker Insider Volume Average
Buy Price
Average
Sell Price
Buy Sell Net
Mar 5/15 MBX   40,000 -40,000   $0.573
To view other marker data and corrections for the past week, sign up for an account or log in above.
To view more historical data and corrections, sign up for an account at inkresearch.com
Sector:  Healthcare Industry:  Biotechnology & Medical Research
 
See Regulatory Filings on SEDAR
Key People
William J. Gastle
Executive Chairman of the Board
Vaughn C. Embro-Pantalony
President, Chief Executive Officer, Director
James A. Long
Chief Financial Officer
Company Contact
Address: 265 Watline Ave
MISSISSAUGA ON L4Z 1P3
Tel: N/A
Website: microbix.com
IR: See website
Business Overview
Microbix Biosystems Inc. develops biological products and technologies. The Company has a Virology Products business, including the manufacturing and sale of cell culture-based biological products and the licensing of technologies. The Company has also developed VIRUSMAX (a virus yield enhancement technology), and Kinlytic (a thrombolytic drug), and is developing LumiSort a semen sexing technology. LumiSort is next generation instrument based (cytometric) technology that will improve the yield and quality of sexed semen while increasing the speed of sex-sorting by an order of magnitude over methods used in the livestock industry. Urokinase is a natural human protein that stimulates the human body's blood clot-dissolving processes. VIRUSMAX technology is a process for recovery of more viruses from influenza virus-infected chick embryos (eggs) to enhance influenza vaccine production.
Financial Overview
For the three months ended 31 December 2014, Microbix Biosystems, Inc. revenues increased 4% to C$2M. Net income decreased 98% to C$2K. Revenues reflect Europe segment increase of 28% to C$1.7M. Net income was offset by Employee benefits in SGA increase from C$114K to C$242K (expense), Interest expense increase of 27% to C$157K (expense).
Employees: 20 as of Sep 30, 2002
Reporting Currency: Canadian Dollars
Enterprise value: $52.26M as of Dec 31, 2014
Annual revenue (TTM): $8.46M as of Dec 31, 2014
EBITDA (TTM): $1.59M as of Dec 31, 2014
Net annual income (TTM): $0.05M as of Dec 31, 2014
Free cash flow (TTM): -$5.34M as of Dec 31, 2014
Net Debt Last Fiscal Year: $5.72M as of Dec 31, 2014
Shares outstanding: 79,478,301 as of Feb 24, 2015
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization
Competitors with Recent Insider Filings
ImmunoVaccine (T:IMV)
AEterna Zentaris (T:AEZ)
Neptune Tech & Biores (T:NTB)
 
Microbix Biosystems Inc. Insider Report Only $20.00